30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

1Q13 Revenue: ConMed

$105MM, -2% (Sports Medicine -3%, Powered Surgical +1%)

  • Noted that healthcare utilization seems flat in the U.S., despite modest job growth
  • Revenue growth impacted by reduction in international healthcare spending, specifically major European countries
  • SportsMed declined due to fewer selling days, weaker European sales; new shoulder products performing well
  • Powered Surgical driven by capital products, handpieces